WPMS HTML Sitemap

Posts

  • Lead article
  • Oblique view
  • 2002, Volume 09, Issue 01, pages 1-56
  • Acute & Interventional Cardiology 2002; Volume 9: pages AIC 1- AIC 32
  • Heart & Brain 2003; Volume 10, Issue 1: pages HB 1 - HN 24
  • Lipids content
  • ACS management
  • Cardiovascular Research 2018 Handbook
  • News and views
  • Opinion
  • 2002, Volume 09, Issue 02, pages 57-124
  • 2013, Volume 20 (online first)
  • Acute & Interventional Cardiology 2003; Volume 10: pages AIC 1- AIC 88
  • Angina book form
  • Angiography
  • Online First
  • 2002, Volume 09, Issue 03, pages 125-184
  • 2014, Volume 21 (online first)
  • Acute & Interventional Cardiology 2004; Volume 11: pages AIC 1- AIC 104
  • Book review
  • Angina
  • Ad test
  • 2002, Volume 09, Issue 04, pages 185-244
  • 2002, Volume 09, Supplement 7: Early thrombolysis – the realities and the practicalities
  • 2015, Volume 22 (online first)
  • Acute & Interventional Cardiology 2005; Volume 12: pages AIC 1- AIC 104
  • Correspondence
  • Anticoagulation
  • Acute and Interventional Cardiology
  • 2002, Volume 09, Issue 05, pages 245-304
  • 2002, Volume 09, Supplement 8: Management of acute coronary artery disease
  • Acute & Interventional Cardiology 2006; Volume 13: pages AIC 1- AIC5 6
  • Course review
  • 2016, Volume 23 (online first)
  • Diabetes and CVD
  • Clinical articles
  • 2002, Volume 09, Issue 06, pages 305-368
  • 2003, Volume 10, Supplement 1: Diet and heart health: emerging evidence
  • ECGs for the fainthearted
  • 2017, Volume 24 (online first)
  • Electrolytes
  • diabetes
  • 2002, Volume 09, Issue 07, pages 369-424
  • 2003, Volume 10, Supplement 2: Socratic dialogue: the future management of hyperlipidaemia
  • In brief
  • Heart failure
  • 2018, Volume 25 (online first)
  • Editorials
  • 2002, Volume 09, Issue 08, pages 425-492
  • 2003, Volume 10, Supplement 3: Drug treatment of hypertension – the future is combination therapy
  • Meeting report
  • Heart valve disease
  • Featured article
  • 2002, Volume 09, Issue 09, pages 493-560
  • 2003, Volume 10, Supplement 4: Phosphodiesterase type 5 (PDE5) inhibitors: looking beyond erectile dysfunction
  • Lipids
  • Heart and Brain
  • Obesity
  • 2002, Volume 09, Issue 10, pages 561-644
  • 2004, Volume 11, Supplement 1: Diet and heart health symposium II
  • Learning
  • 2004, Volume 11, Supplement 2: Improved cardiovascular risk reduction: the evidence for raising HDL cholesterol
  • Pulmonary hypertension
  • Learning Articles
  • Standalone
  • 2004, Volume 11, Supplement 3: A new class in cholesterol management
  • Supplements
  • 2003, Volume 10, Issue 01, pages 1-76
  • 2005, Volume 12, Supplement 1: This House believes that the UK healthcare system may be failing as many as 50% of patients with hyperlipidaemia by not reducing their cholesterol to effective levels
  • 2003, Volume 10, Issue 02, pages 77-160
  • 2005, Volume 12, Supplement 2: National Institute for Clinical Excellence (NICE) recommendations on the use of myocardial perfusion scintigraphy
  • Books
  • Videos
  • 2003, Volume 10, Issue 03, pages 161-240
  • 2006, Volume 13, Supplement 1: Switching statins: what are the issues and implications?
  • Volumes
  • 2003, Volume 10, Issue 04, pages 241-320
  • 2006, Volume 13, Supplement 2: The role of angiotensin-converting enzyme inhibitors in coronary artery disease
  • 2003, Volume 10, Issue 05, pages 321-400
  • 2007, Volume 14, Supplement 1: Best practice principles for cholesterol lowering
  • 2003, Volume 10, Issue 06, pages 401-488
  • 2004, Volume 11, Issue 01, pages 1-80
  • 2007, Volume 14, Supplement 3: Optimising global risk reduction: insights from REACH
  • 2004, Volume 11, Issue 02, pages 81-168
  • 2007, Volume 14, Supplement 4: Direct renin inhibition with aliskiren – a new option in treating hypertension
  • 2004, Volume 11, Issue 03, pages 169-256
  • 2008, Volume 15, Supplement 1: Clinical implications of the inhibition of the late sodium current: a new paradigm in the treatment of ischaemic heart disease
  • 2004, Volume 11, Issue 04, pages 257-332
  • 2008, Volume 15, Supplement 2: Cholesterol management
  • 2004, Volume 11, Issue 05, pages 333-412
  • 2009, Volume 16, Supplement 1: Moving forward in pulmonary arterial hypertension
  • 2004, Volume 11, Issue 06, pages 413-496
  • 2009, Volume 16, Supplement 2: Maximising safety and efficacy in the treatment of wet AMD
  • 2005, Volume 12, Issue 01, pages 1-80
  • 2009, Volume 16, Supplement 3: Multi-management of ischaemic heart disease: do we have the COURAGE of our convictions?
  • 2005, Volume 12, Issue 02, pages 81-160
  • 2010, Volume 17, Supplement 1: Aspirin – reassessing its role in cardiovascular disease
  • 2005, Volume 12, Issue 03, pages 161-244
  • 2010, Volume 17, Supplement 2: Are all angiotensin receptors blockers the same?
  • 2005, Volume 12, Issue 04, pages 245-320
  • 2010, Volume 17, Supplement 3: PCI in the UK – the continuing journey
  • 2005, Volume 12, Issue 05, pages 321-404
  • 2011, Volume 18, Supplement 1: Setting the standard for cardiac rehabilitation
  • 2005, Volume 12, Issue 06, pages 405-476
  • 2011, Volume 18, Supplement 2: Anaemia in chronic heart failure: what constitutes optimal investigation and treatment?
  • 2006, Volume 13, Issue 01, pages 1-76
  • 2011, Volume 18, Supplement 3: The management of stable angina – a perspective on recent guidance
  • 2006, Volume 13, Issue 02, pages 77-156
  • 2012, Volume 19, Supplement 1: Lipids and CVD: improving practice and clinical outcome
  • 2006, Volume 13, Issue 03, pages 157-224
  • 2012, Volume 19, Supplement 2: Chronic stable angina guidelines – is there an emerging international consensus?
  • 2006, Volume 13, Issue 04, pages 225-300
  • 2006, Volume 13, Issue 05, pages 301-372
  • 2013, Volume 20, Supplement 1: Optimising hypertension treatment: NICE/BHS guideline implementation and audit for best practice
  • 2006, Volume 13, Issue 06, pages 373-440
  • 2013, Volume 20, Supplement 2: Acute heart failure – a call to action
  • 2007, Volume 14, Issue 01, pages 1-60
  • 2013, Volume 20, Supplement 3: Cardiovascular health and disease prevention in clinical practice
  • 2007, Volume 14, Issue 02, pages 61-120
  • 2014, Volume 21, Supplement 1: Rivaroxaban in non-valvular atrial fibrillation: European experience
  • 2007, Volume 14, Issue 03, pages 121-180
  • 2014, Volume 21, Supplement 2: Unlocking the potential of NOACs
  • 2007, Volume 14, Issue 04, pages 181-244
  • 2015, Volume 22, Supplement 1: Pulmonary hypertension in UK clinical practice – an update
  • 2007, Volume 14, Issue 05, pages 245-296
  • 2016, Volume 23, Supplement 1: Perspectives in chronic heart failure – new treatment advances
  • 2016, Volume 23, Supplement 2: The future of cardioversion management – new strategies for the use of oral anticoagulation in direct current cardioversion
  • 2008, Volume 15, Issue 01, pages 1-56
  • 2017, Volume 24, Supplement 1: Optimising the management of post-ACS patients
  • 2008, Volume 15, Issue 02, pages 57-112
  • 2018, Volume 25, Supplement 1: Anticoagulation in atrial fibrillation: focus on PIONEER AF-PCI and its implications
  • 2008, Volume 15, Issue 03, pages 113-168
  • 2018, Volume 25, Supplement 2: Management of cardiovascular disease in the patient with diabetes
  • 2008, Volume 15, Issue 04, pages 169-216
  • 2018, Volume 25, Supplement 3: Advances in cardiac pacing – A 60th anniversary update
  • 2008, Volume 15, Issue 05, pages 217-272
  • 2008, Volume 15, Issue 06, pages 274-328
  • 2009, Volume 16, Issue 01, pages 1-48
  • 2009, Volume 16, Issue 02, pages 49-104
  • 2009, Volume 16, Issue 03, pages 105-152
  • 2009, Volume 16, Issue 04, pages 153-200
  • 2009, Volume 16, Issue 05, pages 201-256
  • 2009, Volume 16, Issue 06, pages 257-304
  • 2010, Volume 17, Issue 01, pages 1-48
  • 2010, Volume 17, Issue 02, pages 49-96
  • 2010, Volume 17, Issue 03, pages 97-152
  • 2010, Volume 17, Issue 04, pages 153-200
  • 2010, Volume 17, Issue 05, pages 201-248
  • 2010, Volume 17, Issue 06, pages 250-296
  • 2011, Volume 18 Issue 01, pages 1-48
  • 2011, Volume 18 Issue 02, pages 49-96
  • 2011, Volume 18 Issue 03, pages 97-144
  • 2011, Volume 18 Issue 04, pages 145-192
  • 2011, Volume 18, Issue 5/6, pages 195-248
  • 2012, Volume 19, Issue 1, pages 01-48
  • 2012, Volume 19, Issue 2, pages 49-96
  • 2012, Volume 19, Issue 3, pages 97-144
  • 2012, Volume 19, Issue 4, pages 145-184
  • 2013, Volume 20, Issue 1, pages 5-40
  • 2013, Volume 20, Issue 2, pages 41-80
  • 2013, Volume 20, Issue 3, pages 81-120
  • 2013, Volume 20, Issue 4, pages 121-160
  • 2014, Volume 21, Issue 1, pages 1–40
  • 2014, Volume 21, Issue 2, pages 41–80
  • 2014, Volume 21, Issue 3, pages 81–120
  • 2014, Volume 21, Issue 4, pages 121–160
  • 2015, Volume 22, Issue 1, pages 1–40
  • 2015, Volume 22, Issue 2, pages 41–80
  • 2015, Volume 22, Issue 3, pages 81–120
  • 2015, Volume 22, Issue 4, pages 121–160
  • 2016, Volume 23, Issue 1, pages 1–40
  • 2016, Volume 23, Issue 2, pages 41–81
  • 2016, Volume 23, Issue 3, pages 81–120
  • 2016, Volume 23, Issue 4, pages 121–160
  • 2017, Volume 24, Issue 1, pages 1–40
  • 2017, Volume 24, Issue 2, pages 41–80
  • 2017, Volume 24, Issue 3, pages 81–120
  • 2017, Volume 24, Issue 4, pages 121–160
  • 2018, Volume 25, Issue 1, pages 1–40
  • 2018, Volume 25, Issue 2, pages 41–80
  • 2018, Volume 25, Issue 3, pages 81–120
THERE ARE CURRENTLY NO COMMENTS FOR THIS ARTICLE - LEAVE A COMMENT